CA3249734A1 - LINCOSAMIDES AND THEIR USES - Google Patents

LINCOSAMIDES AND THEIR USES

Info

Publication number
CA3249734A1
CA3249734A1 CA3249734A CA3249734A CA3249734A1 CA 3249734 A1 CA3249734 A1 CA 3249734A1 CA 3249734 A CA3249734 A CA 3249734A CA 3249734 A CA3249734 A CA 3249734A CA 3249734 A1 CA3249734 A1 CA 3249734A1
Authority
CA
Canada
Prior art keywords
compound
substituted
unsubstituted
pharmaceutically acceptable
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3249734A
Other languages
English (en)
French (fr)
Inventor
Andrew G. Myers
Kelvin Wu
Ben Calhoun Tresco
Original Assignee
Harvard University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard University filed Critical Harvard University
Publication of CA3249734A1 publication Critical patent/CA3249734A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CA3249734A 2022-04-20 2023-04-19 LINCOSAMIDES AND THEIR USES Pending CA3249734A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263332993P 2022-04-20 2022-04-20
US63/332,993 2022-04-20
PCT/US2023/019059 WO2023205206A1 (en) 2022-04-20 2023-04-19 Lincosamides and uses thereof

Publications (1)

Publication Number Publication Date
CA3249734A1 true CA3249734A1 (en) 2023-10-26

Family

ID=88420515

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3249734A Pending CA3249734A1 (en) 2022-04-20 2023-04-19 LINCOSAMIDES AND THEIR USES

Country Status (8)

Country Link
US (1) US20250270246A1 (https=)
EP (1) EP4511043A1 (https=)
JP (1) JP2025514802A (https=)
KR (1) KR20250006139A (https=)
CN (1) CN119403559A (https=)
AU (1) AU2023255378A1 (https=)
CA (1) CA3249734A1 (https=)
WO (1) WO2023205206A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026025019A1 (en) 2024-07-26 2026-01-29 President And Fellows Of Harvard College Synthesis of macrobicyclic thiolincosamines
WO2026043875A1 (en) 2024-08-20 2026-02-26 President And Fellows Of Harvard College Synthesis of oxepanoprolines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7361743B2 (en) * 2004-02-11 2008-04-22 Pfizer Inc Lincomycin derivatives possessing antibacterial activity
CZ2017137A3 (cs) * 2017-03-10 2018-05-23 Mikrobiologický ústav AV ČR, v. v. i. Linkosamidy, jejich příprava a použití
WO2021236911A1 (en) * 2020-05-22 2021-11-25 President And Fellows Of Harvard College Lincosamide antibiotics and uses thereof

Also Published As

Publication number Publication date
EP4511043A1 (en) 2025-02-26
JP2025514802A (ja) 2025-05-09
AU2023255378A1 (en) 2024-11-07
CN119403559A (zh) 2025-02-07
WO2023205206A1 (en) 2023-10-26
KR20250006139A (ko) 2025-01-10
US20250270246A1 (en) 2025-08-28

Similar Documents

Publication Publication Date Title
US11634449B2 (en) Macrolides and methods of their preparation and use
US11767341B2 (en) Lincosamide antibiotics and uses thereof
US10640528B2 (en) Macrolides with modified desosamine sugars and uses thereof
CA3249734A1 (en) LINCOSAMIDES AND THEIR USES
JP2025000636A (ja) Ｃ１０－アルキレン置換された１３員マクロライド及びそれらの使用
IL283185B2 (en) Macrolides with 13 members converted to C10-cyclic and their uses
US20230242565A1 (en) Macrolides with Modified Desosamine Sugars and Uses Thereof
WO2019032956A1 (en) LINCONSAMIDE ANTIBIOTICS AND USES THEREOF

Legal Events

Date Code Title Description
A00 Application filed

Free format text: ST27 STATUS EVENT CODE: A-0-1-A10-A00-A101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION RECEIVED - PCT

Effective date: 20241018

A00 Application filed

Free format text: ST27 STATUS EVENT CODE: A-1-1-A10-A00-A102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: COMPLIANCE REQUIREMENTS DETERMINED MET

Effective date: 20241122

A15 Pct application entered into the national or regional phase

Free format text: ST27 STATUS EVENT CODE: A-1-1-A10-A15-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: NATIONAL ENTRY REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20241122

P18 Priority claim added or amended

Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P18-P105 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: PRIORITY CLAIM REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20241122

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20241122

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 2ND ANNIV.) - STANDARD

Year of fee payment: 2

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250411

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250411